RodneyPRocconiMD
Obstetrics & Gynecology • Mobile, ALGynecologic Oncology
Professor of Gynecologic Oncology, University of Alabama at Birmingham Associate Director, Infirmary Cancer Care Director of Research, Infirmary Cancer Care Specializing in preventing, diagnosing, and treating gynecological cancers
Dr. Rocconi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1660 Springhill Avenue
Mobile, AL 36640Phone+1 251-410-1010Fax+1 251-665-8010- Is this information wrong?
Summary
- Dr. Rodney P. Rocconi is a Gynecologic Oncologist, specializing in preventing, diagnosing and treating gynecological cancers. He completed a Fellowship at the University of Alabama at Birmingham in Birmingham, AL. He is an Associate Director for Clinical Research
Education & Training
University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 2000 - 2004
University of Alabama School of MedicineClass of 2000- University of Alabama Medical CenterFellowship, Gynecologic Oncology
Certifications & Licensure
AL State Medical License 2001 - 2024
MS State Medical License 2023 - 2024- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Start of enrollment: 2009 Jun 29
- Join now to see all
Publications & Presentations
PubMed
- Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncol...Zachary A Kopelman, Chunqiao Tian, Jordyn Tumas, Neil T Phippen, Christopher M Tarney, Erica R Hope, Stuart S Winkler, Suzanne Jokajtys, Calen W Kucera, John K Chan, M...> ;Gynecologic Oncology. 2024 Apr 8
- Corrigendum to "Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhib...Chinnadurai Mani, Kaushlendra Tripathi, Sandeep Chaudhary, Ranganatha R Somasagara, Rodney P Rocconi, Chiquito Crasto, Mark Reedy, Mohammad Athar, Komaraiah Palle> ;Neoplasia. 2024 Apr 1
- Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.Calen W Kucera, Nicole P Chappell, Chunqiao Tian, Michael T Richardson, Christopher M Tarney, Chad A Hamilton, John K Chan, Daniel S Kapp, Charles A Leath 3rd, Yovanni...> ;Gynecologic Oncology. 2024 Feb 9
- Join now to see all
Press Mentions
Gradalis to Host Key Opinion Leader Webinar on Unmet Medical Needs in Ovarian Cancer and the Company’s Immuno-Oncology Treatment, Vigil®September 28th, 2022- 14th Annual GO Run 5K Stays Virtual for 2021August 17th, 2021
Why Are More Black Women Dying from the Most Common Reproductive Cancer?October 21st, 2019- Join now to see all
Professional Memberships
- Member
- Fellow
Hospital Affiliations
- Mobile Infirmary Medical CenterMobile, Alabama
- USA Health Children's & Women's HospitalMobile, Alabama
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
